ANIP
ANI Pharmaceuticals Inc
76.10$
+1.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 20.5% | 16.6% | 37.9% | 44.7% | 36.2% | 30.6% | 41.8% | 46.5% | 43.9% | 37.3% | 40.7% | 49.0% | |
| 79.5% | 83.4% | 62.1% | 55.3% | 63.8% | 69.4% | 58.2% | 53.5% | 56.1% | 62.7% | 59.3% | 51.0% | |
| 4.8% | 3.8% | 2.3% | 5.1% | 7.6% | 9.6% | 7.7% | 5.3% | 7.1% | 7.0% | 7.3% | 5.8% | |
| 32.0% | 27.7% | 21.6% | 17.9% | 21.9% | 27.0% | 31.2% | 39.0% | 40.4% | 30.9% | 40.6% | 36.0% | |
| 43.8% | 40.5% | 41.3% | 38.8% | 46.2% | 61.5% | 65.9% | 71.9% | 67.3% | 53.1% | 59.2% | 41.8% | |
| 35.7% | 42.8% | 15.6% | 16.0% | 17.5% | 7.9% | -7.7% | -18.4% | -11.2% | 9.6% | 0.1% | 9.2% | |
| 1.4% | 14.4% | 8.8% | 6.8% | 7.3% | 6.3% | 4.5% | 5.5% | 8.9% | 5.5% | 2.9% | 2.3% | |
| 34.6% | 28.5% | 6.7% | 9.2% | 9.9% | 1.5% | -12.5% | -25.9% | -19.8% | 4.1% | -3.6% | 10.8% | |
| -16.7% | 8.3% | 3.7% | 9.9% | 2.3% | -1.4% | -1.6% | -6.2% | -4.7% | 0.2% | -0.6% | 2.0% | |
| 51.4% | 20.1% | 3.1% | -0.6% | 7.7% | 3.0% | -10.8% | -19.7% | -15.1% | 3.9% | -3.0% | 8.9% | |
| 43.0% | 51.9% | 43.8% | 32.3% | 34.3% | 29.4% | 13.5% | 1.4% | 7.9% | 21.9% | 10.3% | 23.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.